Skip to main content
Richard Schlenk, MD, Neurosurgery, Cleveland, OH

RichardSchlenkMD

Neurosurgery • Cleveland, OH

Neurosurgical Spine Surgery

Neurosurgery Residency Program Director at Cleveland Clinic

Join to view full profile

Dr. Schlenk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schlenk's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    Cleveland, OH 44195
    Phone+1 800-223-2273

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Neurosurgical Spine Surgery, 2002 - 2003
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Neurological Surgery, 1997 - 2002
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 1995 - 1997
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1995

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2002 - 2026
  • NJ State Medical License
    NJ State Medical License 1998 - 2003
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow (FAANS) American Association of Neurological Surgeons

Publications & Presentations

PubMed

Press Mentions

  • VANFLYTA® Approved in the EU as the First FLT3 Inhibitor Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML
    VANFLYTA® Approved in the EU as the First FLT3 Inhibitor Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AMLNovember 10th, 2023

Professional Memberships

Dr. Richard Schlenk, Dr. Richard Schlenk, MD, Dr. R Schlenk